JCB logo
Avanti Polar Lipids, Inc.
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents
Published online
doi:10.1083/jcb.200709069
The Journal of Cell Biology, Vol. 180, No. 5, 947-955
The Rockefeller University Press, 0021-9525 $30.00
© Galabova-Kovacs et al.
This Article
Right arrow Full Text
Right arrow Full Text (PDF, 2922K)
Right arrow PPT slides of all figures
Right arrow Supplemental Material Index
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JCB
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Galabova-Kovacs, G.
Right arrow Articles by Baccarini, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Galabova-Kovacs, G.
Right arrow Articles by Baccarini, M.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Article

Essential role of B-Raf in oligodendrocyte maturation and myelination during postnatal central nervous system development



Gergana Galabova-Kovacs1, Federica Catalanotti1, Dana Matzen1, Gloria X. Reyes1, Jürgen Zezula2, Ruth Herbst3, Alcino Silva4, Ingrid Walter5, and Manuela Baccarini1

1 Max F. Perutz Laboratories, University of Vienna, 1030 Vienna, Austria
2 Institute of Pharmacology, Center of Biomolecular Medicine and Pharmacology, and 3 Center for Brain Research, Medical University of Vienna, 1090 Vienna, Austria
4 National Institute of Mental Health, Bethesda, MD 20892
5 Department of Histology and Embryology, University of Veterinary Medicine, 1210 Vienna, Austria

Correspondence to M. Baccarini: manuela.baccarini{at}univie.ac.at

Mutations in the extracellular signal-regulated kinase (ERK) pathway, particularly in the mitogen-activated protein kinase/ERK kinase (MEK) activator B-Raf, are associated with human tumorigenesis and genetic disorders. Hence, B-Raf is a prime target for molecule-based therapies, and understanding its essential biological functions is crucial for their success. B-Raf is expressed preferentially in cells of neuronal origin. Here, we show that in mice, conditional ablation of B-Raf in neuronal precursors leads to severe dysmyelination, defective oligodendrocyte differentiation, and reduced ERK activation in brain. Both B-Raf ablation and chemical inhibition of MEK impair oligodendrocyte differentiation in vitro. In glial cell cultures, we find B-Raf in a complex with MEK, Raf-1, and kinase suppressor of Ras. In B-Raf–deficient cells, more Raf-1 is recruited to MEK, yet MEK/ERK phosphorylation is impaired. These data define B-Raf as the rate-limiting MEK/ERK activator in oligodendrocyte differentiation and myelination and have implications for the design and use of Raf inhibitors.

F. Catalanotti and D. Matzen contributed equally to this paper.

Abbreviations used in this paper: CNS, central nervous system; ERK, extracellular signal-regulated kinase; KO, knockout; KSR, kinase suppressor of Ras; MBP, myelin basic protein; MEK, MAPK/ERK kinase; P, postnatal day; PDGFR{alpha}, PDGF receptor {alpha}; WT, wild type.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?




  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents